Amoxicillin 250 & 500 Portfolio Capsules
PDF Leaflet Revision Date: 16 May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Infections caused by susceptible non-penicillinase-producing organisms.
Dosage (summary)
250 mg every 8 hours; 500 mg for severe infections.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Limited data show no increased risk in pregnancy; excreted in breast milk with possible infant effects.
Key Drug Interactions
- Probenecid
- Allopurinol
- Tetracyclines
- Oral anticoagulants
Contraindications
- Hypersensitivity to amoxicillin
- History of severe hypersensitivity to beta-lactams
- Infectious mononucleosis
Common side effects
- Diarrhoea
- Nausea
- Skin rash
Counselling Points
- Take with water without opening capsules
- Monitor for allergic reactions
- Report severe diarrhea immediately
Serious warnings
- Serious hypersensitivity reactions
- Convulsions in renal impairment
- Antibiotic-associated colitis
Important Disclaimer
The Amoxicillin 250 & 500 Portfolio Capsules professional information leaflet below is the property of Portfolio Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
